You are here

Vaxfectin

Vical’s Herpes Vaccine Didn’t Meet Primary Endpoint

WSJ Online

Tue, 06/23/15 - 11:04 am

Vical says privately held Cyvax will use its Vaxfectin technology in malaria vaccines

Yahoo/AP

Wed, 12/5/12 - 12:06 pm

Vical and Bristol-Myers Ink Deal

Yahoo/Zacks

Mon, 09/17/12 - 03:50 pm

Bristol-Myers Squibb

Vical's Vaxfectin Comes Alive

Seeking Alpha

Thu, 09/13/12 - 04:03 pm

Bristol-Myers Squibb

metastatic melanoma

Vical says bird flu drug candidate was safe and effective in early trial

Yahoo/AP

Fri, 02/13/09 - 08:45 am